Abstract

Aims In patients with coronary artery disease acetylcholine (a muscarinic agonist) causes vasoconstriction. The effect of atropine (a muscarinic antagonist) on coronary vasotone in patients with normal or impaired left ventricular function is unknown.

Methods and Results Twenty-four patients who required atropine infusion (to supplement heart rate response) during atrial pacing (pacing was conducted to assess ischaemia as part of an experimental protocol) were studied; 17 patients had normal and seven impaired left ventricular function (ejection fraction ≤0·40). Two control groups were selected from a large database (from patients in whom atrial pacing was carried out but to whom atropine was not administered) to match the normal (n=20) and dysfunction (n=10) groups. In the normal left ventricular function group atropine increased rate pressure product by 12±4%, as compared to those without atropine (P<0·05). Left ventricular end diastolic pressure increased less in the atropine group (+40±8% vs +78±6%;P<0·05). Arterial norepinephrine increased similarly in both groups, but coronary flow (as assessed by using a thermodiluting method in the coronary sinus) increased 23±4% more in the atropine group (P<0·05). Further, there were lower levels of myocardial lactate production and ST-segment depression in the atropine group [lactate extraction +13±6% (atropine) vs −19±4% (controls), ST-segment depression 1·3±0·6 (atropine) vs 1·8±0·2mm (control), both P<0·05 between groups]. In contrast, in the dysfunction group the overall effect of atropine was less pronounced.

Conclusion In patients with normal left ventricular function atropine improves coronary flow and reduces myocardial lactate production and ST-segment depression during atrial pacing, suggesting a reduction in myocardial ischaemia.

f1
Correspondence: Dr A.F.M. van den Heuvel, Dept. of Cardiology/Thoraxcenter, University Hospital Groningen, P.O. ox 30.001, 9700 RB Groningen, The Netherlands.

References

1
Feigl
EO
. Parasympathetic control of coronary blood flow in dogs.
Circ Res
 .
1969
;
25
:
509
–519
2
Hackett
JG
, Abboud FM, Mark AL, Schmid PG, Heistad DD. Coronary vascular responses to stimulation of chemoreceptors and baroreceptors.
Circ Res
 .
1972
;
31
:
8
–17
3
Ito
BR
, Feigl EO. Carotid chemoreceptor reflex parasympathetic coronary vasodilation in the dog.
AM J Physiol
 .
1985
;
249
:
H1167
–1175
4
Denn
MJ
, Stone HL. Autonomic innervation of dog coronary arteries.
J Appl Physiol
 .
1976
;
412
:
30
–35
5
Gerova
M
, Dolezel S, Gero J, Barta E. Role of the vagus in control of the major conduit artery in the dog.
Physiol Bohemoslov
 .
1979
;
28
:
299
–307
6
Cox
DA
, Hintze TH, Vatner SF. Effects of acetylcholine on large and small coronary arteries in conscious dogs.
J Pharmacol Exp Ther
 .
1983
;
225
:
764
–769
7
Young
MA
, Knight DR, Vatner SF. Autonomic control of large coronary arteries and resistance vessels.
Prog Cardiovasc Dis
 .
1987
;
30
:
211
–234
8
Brunner
F
, Kuhlberger E, Schloos J, Kukovetz WR. Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies.
Eur J Pharmacol
 .
1991
;
196
:
247
–255
9
Hendriks
MGC
, Pfaffendorf M, van Zwieten PA. Characterization of the muscarinic receptors in the mesenteric vascular bed of spontaneously hypertensive rats.
J Hypertension
 .
1993
;
11
:
1329
–1335
10
Ludmer
PL
, Selwyn AP, Shook TL. Paradoxical vasoconstriction induced y acetylcholine in atherosclerotic coronary arteries.
N Engl J Med
 .
1986
;
315
:
1046
–1051
11
Zeiher
AM
, Drexler H, Wollschläger H, Just H. Preserved flow mediated vasodilation despite acetylcholine-induced vasoconstriction in atherosclerotic coronary arteries in man (Astr).
J Am Coll Cardiol
 .
1989
;
13
:
132
12
Remme
WJ
, Van de Berg MD, Mantel M. Temporal relation of changes in regional coronary flow and myocardial lactate and nucleoside metabolism in humans during pacing-induced ischemia.
Am J Cardiol
 .
1986
;
58
:
1188
–1194
13
Van Den Heuvel
AFM
, van der Ent M, van Veldhuisen DJ, Kruijssen DACM, Bartels GL, Remme WJ. Effects of epanolol, a selective β1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
J Cardiovasc Pharmacol
 .
1998
;
31
:
506
–512
14
van Zwieten
PA
, Doods HN. Muscarinic receptors and drugs in cardiovascular medicine.
Cardiovasc Drugs Ther
 .
1995
;
9
:
159
–167
15
Ganz
W
, Tamura K, Marcus HS, Donoso R, Yoshida S, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man.
Circulation
 .
1971
;
44
:
181
–195
16
Grossman
W
, Baim DS. Cardiac Catheterization, Angiography and Intervention. Philadelphia, London: Lea & Febiger; 1991.
17
Maseri
A
, Crea F, Cianflone D. Myocardial ischemia caused by distal coronary vasoconstriction.
Am J Cardiol
 .
1992
;
70
:
1602
–1605
18
Marraccini
P
, Orsini E, Nassi G, L'Abbate A. Effects of parasympathetic blockade on ischemic threshold in patients with exercise-induced myocardial ischemia.
Am J Cardiol
 .
1991
;
68
:
539
–542
19
Eckberg
DL
. Parasympathetic cardiovascular control in human disease: a critical review of methods and results.
Am J Physiol
 .
1980
;
239
:
H581
–593
20
Brouwer
J
, van Veldhuisen DJ, Man in't Veld AJ, Dunselman PHJM, Boomsma F, Haaksma J, Lie KI. Heart rate variability in patients with mild to moderate heart failure: effects of neurohumoral modulation by digoxin and ibopamine.
J Am Coll Cardiol
 .
1995
;
26
:
983
–990
21
Vatner
SF
, Hittinger L. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure.
J Am Coll Cardiol
 .
1993
;
22
:
34A
–40A
22
Furchgott
RF
, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.
Nature
 .
1980
;
288
:
373
–376
23
Bassenge
E
, Busse R. Endothelial modulation of coronary tone.
Prog Cardiovasc Dis
 .
1988
;
5
:
349
–380
24
Endoh
M
, Hirosawa K, Kaneko N, Hase C, Inoue Y, Konno S. Prinzmetal's variant angina; coronary arteriogram and ventriculogram during attack induced by methacholine.
N Engl J Med
 .
1976
;
294
:
252
–254
25
Busse
R
, Trogish G, Bassenge E. The role of endothelium in the control of vascular tone.
Basic Res Cardiol
 .
1985
;
80
:
475
–490
26
Nabel
EG
, Selwin AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium dependent mechanism that fails in patients with atherosclerosis.
J Am Coll Cardiol
 .
1990
;
16
:
349
–356
27
Baumgart
D
, Heusch G. Neuronal control of blood flow.
Basic Res Cardiol
 .
1995
;
90
:
142
–159
28
Hasdai
D
, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects.
Circulation
 .
1997
;
96
:
3390
–3395
29
Schroder
K
, Agrawal R, Voller H, Kursten B, Dissmann R, Schultheiss HP. Factors influencing the diagnostic accuracy of dobutamine stress echocardiography.
Int J Card Imaging
 .
1997
;
13
:
493
–498
30
Remme
WJ
, Kruyssen DACM, Look MP, Bootsma M, De Leeuw PW. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans.
J Am Coll Cardiol
 .
1994
;
23
:
82
–91
31
Haunstetter
A
, Haass M, Yi X, Kruger C, Kubler W. Muscarinic inhibition of cardiac norepinephrine and neuropeptide Y release during ischemia and reperfusion.
Am J Physiol
 .
1994
;
267
:
R1552
–1558

Comments

0 Comments